F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) Short Interest Up 63.9% in August

F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) saw a large increase in short interest during the month of August. As of August 14th, there was short interest totaling 18,771 shares, an increase of 63.9% from the July 30th total of 11,453 shares. Based on an average daily volume of 3,579 shares, the days-to-cover ratio is currently 5.2 days. Currently, 0.7% of the company’s shares are short sold.

Institutional Trading of F/m Emerald Life Sciences Innovation ETF

A hedge fund recently raised its stake in F/m Emerald Life Sciences Innovation ETF stock. Hunter Associates Investment Management LLC lifted its holdings in shares of F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) by 8.3% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 49,739 shares of the company’s stock after purchasing an additional 3,831 shares during the period. Hunter Associates Investment Management LLC owned 1.86% of F/m Emerald Life Sciences Innovation ETF worth $1,736,000 at the end of the most recent reporting period.

F/m Emerald Life Sciences Innovation ETF Trading Down 0.4%

Shares of LFSC traded down $0.17 during trading hours on Monday, hitting $45.79. 4,439 shares of the stock were exchanged, compared to its average volume of 4,648. F/m Emerald Life Sciences Innovation ETF has a fifty-two week low of $27.67 and a fifty-two week high of $48.78. The business has a 50-day moving average of $46.08 and a 200-day moving average of $40.13.

F/m Emerald Life Sciences Innovation ETF Company Profile

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.